Overall, the delayed tumor growth by MSH2 KO tumors, especially following PD-1 blockade, correlates with an increased immune infiltration comprised of T cells, including activated CD8+ T cell subsets expressing TCF, DCs, neutrophils and MHC+ C1Q+ CXCL9+ macrophages. The gene discussed is PDCD1; the disease is neoplasm.